Taysha Gene Therapies Inc (TSHA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.32B
Last updated: Nov 17, 2026 at 4:11 PM ET
Taysha Gene Therapies Inc (TSHA) Stock Chart
Taysha Gene Therapies (TSHA) has a latest price of $4.00 on Nov 17, 2026, 45.2% below its 52-week high of $7.30. Its price fell 3.1% over the past 12 months. The month-end price fell 73.6% over the 5 years through Oct 2026, a compound annual decline of 23.4%.
Price Chart
From Sep 2020 to Oct 2026, its highest month-end close was $26.54 in Dec 2020 and its lowest $0.66 in Jun 2023, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart TSHA with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for TSHA.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 37.8%, and over 6 months it fell 22.9%. The month-end price rose 76.5% over the 3 years through Oct 2026, a compound annual rate of 20.8%.
| Period | Change |
|---|---|
| 1 month | +1.5% |
| 3 months | -37.8% |
| 6 months | -22.9% |
| 12 months | -3.1% |
| 12 months, with dividends | -3.1% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +76.5% | +20.8% |
| 5 years | -73.6% | -23.4% |
Price by Year
Its best calendar year was 2025, when the price rose 217.9%, and its weakest was 2022, when it fell 80.6%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $4.13 | -24.9% |
| 2025 | $5.50 | +217.9% |
| 2024 | $1.73 | -2.3% |
| 2023 | $1.77 | -21.7% |
| 2022 | $2.26 | -80.6% |
| 2021 | $11.65 | -56.1% |
Trading Range
The price is 9.7% below its 50-day average of $4.43 and 24.4% below its 200-day average of $5.29.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $4.00 | |
| 52-week high | $7.30 | -45.2% |
| 52-week low | $3.46 | +15.8% |
| 50-day average | $4.43 | -9.7% |
| 200-day average | $5.29 | -24.4% |
Price Risk
Over 3 years, its largest fall from a peak was 72.9%.
| Measure | Value |
|---|---|
| 1-year beta | 1.69 |
| Largest fall, 1 year | -49.7% |
| Largest fall, 3 years | -72.9% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About TSHA
What is TSHA's 1-year price change?
Taysha Gene Therapies's price fell 3.1% over the past 12 months. With dividends included, the 12-month total return was -3.1%.
What is TSHA's 5-year price change?
Taysha Gene Therapies's month-end price fell 73.6% over the 5 years through Oct 2026, a compound annual decline of 23.4%. These figures leave out dividends.
What is TSHA's 52-week high and low?
Taysha Gene Therapies's 52-week high is $7.30 and its 52-week low is $3.46. Its latest price of $4.00 on Nov 17, 2026 is 45.2% below the high.
What is TSHA's beta?
Taysha Gene Therapies's 1-year beta against the S&P 500 is 1.69, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 49.7%.
Is the TSHA chart free?
Yes. Advanced Charting for TSHA is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
TSHA pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors